SYK Stryker Corporation
Healthcare$313.00-1.10%ClosedMarket Cap: $119.99B
As of 2026-05-26
Valuation
P/E (TTM)
39.15
PEG
4.63
P/B
5.43
P/S
4.80
EV/EBITDA
22.94
DCF Value
$318.34
FCF Yield
3.8%
Div Yield
1.1%
Margins & Returns
Gross Margin
63.7%
Operating Margin
21.3%
Net Margin
13.2%
ROE
15.2%
ROA
7.2%
ROIC
9.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $6.02B | 63.3% | $936.0M | $745.0M | $— | $1.76 |
| Q4 null | $7.17B | 65.2% | $1.96B | $849.0M | $— | $1.72 |
| FY null | $25.12B | 64.0% | $4.89B | $3.25B | $— | $4.24 |
| Q3 null | $6.06B | 63.6% | $1.14B | $859.0M | $— | $1.68 |
| Q2 null | $6.02B | 62.3% | $1.36B | $884.0M | $— | $1.68 |
| Q1 null | $5.87B | 62.7% | $1.18B | $654.0M | $— | $1.68 |
| Q4 null | $6.44B | 62.0% | $1.66B | $546.0M | $— | $1.64 |
| FY null | $22.59B | 61.9% | $5.06B | $2.99B | $— | $4.04 |
| Q3 null | $5.49B | 61.8% | $1.21B | $834.0M | $— | $1.60 |
| Q2 null | $5.42B | 61.3% | $1.16B | $825.0M | $— | $1.60 |
| Q1 null | $5.24B | 60.9% | $1.00B | $788.0M | $— | $1.60 |
| Q4 2023 | $5.82B | 61.1% | $1.43B | $1.14B | $2.98 | $1.55 |